| This week's sponsor is Pfizer CentreOne. | |  | |
| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Tuesday, October 2, 2018 All of our Fierce 15 winners care deeply about biomedical science and understand the unique pressure to translate every penny they've raised into something truly innovative for patients. And it seems this passion is infectious when it comes to luring investors. |
|
|
| This week's sponsor is Biotech Primer. | |  | |
Top Stories Of The Week Monday, October 1, 2018 Nektar Therapeutics is a multibillion-dollar biotech with most of its value tied to a single drug—and that drug simply doesn’t work, according to a just-published report. Friday, September 28, 2018 Look out, Eli Lilly: Teva is launching its generic version of the erectile dysfunction drug Cialis in the U.S. Sales of the heavily advertised branded version, which brought in $2.3 billion last year, are expected to fall to $55 million by 2022, putting pressure on Lilly to forge into new and lucrative markets. Tuesday, October 2, 2018 Roche has licensed an anti-cancer bispecific antibody from GO Therapeutics. The deal gives Roche a license for antibodies generated against a novel cancer target and the right to develop a bispecific antibody. Tuesday, October 2, 2018 Bayer’s divisions are trading at a discount, and a breakup could not only rev that up but also focus the company and potentially free up cash for deals that would beef up its less-than-exciting pharma pipeline, a Bernstein analyst figures. Sunday, September 30, 2018 More than a decade ago, scientists at the National Cancer Institute began investigating the idea of using patients’ own immune cells to treat their HER2-positive cancers. Now they are reporting promising results from a small trial of the technique in patients whose tumors overexpress the protein. Wednesday, October 3, 2018 Roche and Novartis are hoping to keep aging Xolair competitive for as long as possible, and they recently took a big step forward in doing just that. Tuesday, October 2, 2018 Digital therapeutics company Click has been on a small hiring spree, bringing new medical and regulatory executives into the fold. Randall Kaye, M.D., and Austin Speier have joined the young company’s top ranks, the former as its chief medical officer and the latter as its chief strategy officer. Wednesday, October 3, 2018 Merck & Co. is out of stock and dealing with back orders of some of its Sinemet Parkinson’s disease drug products that won't be resolved until next year. The issues have resulted from manufacturing problems at the CMO that produces the drug for Merck, and because the drugmaker badly missed its forecast for demand. Wednesday, October 3, 2018 San Francisco-based clinical-stage life science company Recardio is halting clinical trials in the U.K. of a new heart drug due to concerns about Brexit and how new drugs will be approved. Friday, September 28, 2018 European drug regulators and GlaxoSmithKline have quickly rallied their rebuttals to a BMJ report, calling it “flawed and misleading.” The report questioned the safety profile of GSK’s now-unavailable pandemic flu vaccine Pandemrix, as well as the lack of transparency over drug information. | This week's sponsor is the Fierce Innovation Awards – Life Sciences Edition. | |  | |
Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: RWS Life Sciences Examine the linguistic and cultural considerations of global eCOA and BYOD. Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Amazon Web Services Download our new eBook to learn how Healthcare and Life Sciences organizations are taking advantage of solutions from AWS and the AWS Partner Network to obtain value from critical data. Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Reprints Desk, Inc. Go from Search to Full-Text Scientific Papers in a Single Click! Sponsored by: Docusign Life sciences companies must immediately identify and realize productivity gains to drive down operational costs—or risk seeing more nimble competitors disappear into the distance. Where to begin? Sponsored by: Veeva A top 20 pharma and growing biotech re-engineer regulatory processes. Sponsored by: Sciformix Are automation, big data and artificial intelligence (AI) a key part of your company’s pharmacovigilance strategy? Read this whitepaper to know what they should be! Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. Sponsored by: AWS and Tableau Inova is using the capabilities of Tableau on AWS to identify biomarkers for personalized treatment intended to improve health outcomes for children. Sponsored by: AWS and Reltio Reltio and IQVIA provide holistic data management solutions for traditional pharma, emerging biotech, and consumer health companies, on AWS. Presented by: AWS and Druva Life Sciences organizations are embracing cloud-based Master Data Management (MDM) to modernize the organization of critical data. Sponsored by: Catalent Develop a basic understanding of principles and concepts of bioavailability of oral drugs. | 
